5Nakamura A,Shikata K,Hiramatsu M,et al.Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.Diabetes Care,2005,28:2890-2895. 被引量：1
6Navarro J F,Mora C,Gómez M,et al.Influence of renal involvement on peripheral blood mononuelear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.Nephrol Dial Transplant,2008,23:919-926. 被引量：1
7Wong C K,Ho A W,Tong P C,et al.Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy.Clin Exp Immunol,2007,149:123-131. 被引量：1
8Araki S,Haneda M,Koya D,et al.Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes:an observational follow-up study.Diabetologia,2007,50:867-873. 被引量：1
9Allard J,Buléon M,Cellier E,et al.ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats.Am J Physiol Renal Physiol,2007,293:F1083-F1092. 被引量：1
10Kang E S,Kim H J,Ahn C W,et al.Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes.Diabetes Res Clin Pract,2005,69:151-159. 被引量：1
